TRPV4 and hepatocellular carcinoma: Inhibition of TRPV4/calcium/NF-κB signaling pathway attenuates hepatic oxidative stress and inflammatory injury.The combination of TM and HAL has great potential for the treatment of hepatocellular carcinoma by reducing tumour hypoxia and angiogenesis.